Literature DB >> 28105265

Targeting the Inhibition of Tryptophan 2,3-Dioxygenase (TDO-2) for Cancer Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID： 28105265      PMCID： PMC5238467          DOI： 10.1021/acsmedchemlett.6b00458

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy.

Authors:  Christopher J D Austin; Louis M Rendina
Journal:  Drug Discov Today       Date:  2014-12-03       Impact factor: 7.851

Review 2.  Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion.

Authors:  Michael Platten; Wolfgang Wick; Benoît J Van den Eynde
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

Review 3.  TDO as a therapeutic target in brain diseases.

Authors:  Cheng-Peng Yu; Ze-Zheng Pan; Da-Ya Luo
Journal:  Metab Brain Dis       Date:  2016-04-13       Impact factor: 3.584

Review 4.  Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.

Authors:  Lijie Zhai; Stefani Spranger; David C Binder; Galina Gritsina; Kristen L Lauing; Francis J Giles; Derek A Wainwright
Journal:  Clin Cancer Res       Date:  2015-10-30       Impact factor: 12.531
  4 in total
  10 in total

Review 1.  Targeting TDO in cancer immunotherapy.

Authors:  Cheng-Peng Yu; Yun-Lei Song; Zheng-Ming Zhu; Bo Huang; Ying-Qun Xiao; Da-Ya Luo
Journal:  Med Oncol       Date:  2017-03-29       Impact factor: 3.064

Review 2.  Discovery of IDO1 Inhibitors: From Bench to Bedside.

Authors:  George C Prendergast; William P Malachowski; James B DuHadaway; Alexander J Muller
Journal:  Cancer Res       Date:  2017-12-15       Impact factor: 12.701

Review 3.  Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.

Authors:  George C Prendergast; William J Malachowski; Arpita Mondal; Peggy Scherle; Alexander J Muller
Journal:  Int Rev Cell Mol Biol       Date:  2017-09-21       Impact factor: 6.813

4.  Transcriptome Profiling Reveals Distinct Phenotype of Human Bone Marrow Mesenchymal Stem Cell-derived Hepatocyte-like cells.

Authors:  Dongyan Shi; Jiaojiao Xin; Yingyan Lu; Wenchao Ding; Jing Jiang; Qian Zhou; Suwan Sun; Beibei Guo; Xingping Zhou; Jun Li
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

5.  TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway.

Authors:  Lei Li; Tao Wang; Shanbao Li; Zhengqian Chen; Junyi Wu; Wanyue Cao; Qi Wo; Xuebin Qin; Junming Xu
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

Review 6.  Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives.

Authors:  Florent Peyraud; Jean-Philippe Guegan; Dominique Bodet; Sophie Cousin; Alban Bessede; Antoine Italiano
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 7.  Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Alicja Przybyszewska-Podstawka; Dariusz Pawlak
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

8.  Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.

Authors:  Christin Riess; Björn Schneider; Hanna Kehnscherper; Julia Gesche; Nina Irmscher; Fatemeh Shokraie; Carl Friedrich Classen; Elisa Wirthgen; Grazyna Domanska; Annette Zimpfer; Daniel Strüder; Christian Junghanss; Claudia Maletzki
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

9.  Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.

Authors:  Suat Sari; Petr Tomek; Euphemia Leung; Jóhannes Reynisson
Journal:  Molecules       Date:  2019-11-28       Impact factor: 4.411

Review 10.  Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells.

Authors:  Jilan Liu; Xianyun Qin; Dongfeng Pan; Bin Zhang; Feng Jin
Journal:  Stem Cells Int       Date:  2019-12-05       Impact factor: 5.443
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.